RxDoctor Payments Data

Evelyn Fleming, MD

Gynecologic Oncology · Lebanon, NHNPI 1780616219

Payments from drug & device makers

$2,185,359in general payments, 2019–2025

Across 183 payments — averaging $11,942 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Tesaro, Inc.$880K
  • GSK$595K
  • Merck$450K
  • Genentech, Inc.$193K
  • Eli Lilly$37K
  • AstraZeneca$31K
  • plus $264 from 3 others

What the payments were for

  • Travel & lodging$1,19957%
  • Food & beverage$73335%
  • Education$1718%

General payments by program year

19
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Tesaro, Inc.22$879,566
GSK59$594,630
Merck62$450,008
Genentech, Inc.26$193,263
Eli Lilly5$36,646
AstraZeneca6$30,983
AbbVie1$125
Incyte Corporation1$91
Intuitive Surgical1$48

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few gynecologic oncology providers in New Hampshireto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$41,726
Medicare patients
195
Services billed
498

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin13$114

Paid to pharmacies, not to this prescriber.

Other gynecologic oncology in Lebanon

Where these figures come from

Is this you, or does something look wrong? →